Health Ministry Expands QR Code-Based Drug Traceability to Vaccines, Antimicrobials and Anti-Cancer Medicines

📌 Summary:

• The Ministry of Health and Family Welfare notified amendments to the Drugs Rules, 1945, expanding Schedule H2 to bring more drug categories under the QR Code-based track-and-trace framework
• Newly covered: all vaccines, all antimicrobials, narcotic and psychotropic drugs under the NDPS Act, 1985, and all anti-cancer drugs
• Schedule H2 mandates a Bar Code or QR Code on primary packaging (or secondary, if space is inadequate) to enable authentication and traceability across the supply chain
• The QR Code must carry nine data elements: unique product code, generic name, brand name, manufacturer name/address, batch number, manufacture date, expiry date, manufacturing licence number, and excipient details
• Earlier, QR codes were mandatory only for the top 300 pharma brands; this amendment significantly widens coverage to curb spurious/substandard medicines and strengthen supply-chain integrity

🎯 UPSC Relevance: GS2 Governance (Health) — regulatory strengthening of drug safety, anti-counterfeiting and citizen health protection via digital traceability.

📝 Prelims Facts:

• Legal basis: Schedule H2 of the Drugs Rules, 1945; references the NDPS Act, 1985
• QR/Bar Code carries nine prescribed data elements
• Earlier scope was the top 300 pharma brands; now extended to all vaccines, antimicrobials, NDPS drugs and anti-cancer medicines

🔑 Key Term: Track and Trace — a system to follow a product through the supply chain via unique identifiers (e.g. QR codes), enabling authentication and recall of unsafe or counterfeit goods.